Nature Communications · 2016 · 61 citations · 37 references
Life SciencesGeneticsOncologyGene ExpressionMolecular OncologyTranscriptional RegulationCancer EpigeneticsChromatinEpigenetic Regulation In CancerHistone ModificationsHistone ProteinsHistone VariantsCancer Cell MigrationCancer Epigenetic BiomarkersGenetic Prognostic MarkersHistone Variant H3.3Histone Variant RegulationIntronic Regulatory ElementsPrognostic Tumor MarkersTherapeutic Epigenetics
Although several somatic single nucleotide variations in histone H3.3 have been investigated as cancer drivers, other types of aberration have not been well studied. Here, we demonstrate that overexpression of H3F3A, encoding H3.3, is associated with lung cancer progression and promotes lung cancer cell migration by activating metastasis-related genes. H3.3 globally activates gene expression through the occupation of intronic regions in lung cancer cells. Moreover, H3.3 binding regions show characteristics of regulatory DNA elements. We show that H3.3 is deposited at a specific intronic region of GPR87, where it modifies the chromatin status and directly activates GPR87 transcription. The expression levels of H3F3A and GPR87, either alone or in combination, are robust prognostic markers for early-stage lung cancer, and may indicate potential for the development of treatments involving GPR87 antagonists. In summary, our results demonstrate that intronic regulation by H3F3A may be a target for the development of novel therapeutic strategies.
37
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu et al. · Nature · 2012 · 2.7K citations